Total joint arthroplasty patients who experience the minimal clinically important difference for worsening (MCID-W) have higher revision rates at 1, 3, and 5 years postoperatively:
Archives of Orthopaedic and Trauma Surgery · 2025
DOI: 10.1007/s00402-025-06068-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, 2025. Verfasst von Perry L Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Boston, USA. Hauptthemen laut MEDLINE: Reoperation, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Minimal Clinically Important Difference. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The Minimal Clinically Important Difference (MCID) is critical in assessing patient-reported outcomes following total joint arthroplasty (TJA). Although many studies consider the MCID for Improvement (MCID-I), thresholds have also been defined for the MCID for Worsening (MCID-W). However, the potential impact of the MCID-W on surgical outcomes in TJA is under-investigated. This study investigated the association between the MCID-W and revision rate. MATERIALS AND METHODS: This retrospective study was performed using 2787 primary TJAs-1563 total knee arthroplasties (TKAs) and 1224 total hip arthroplasties (THAs)-with minimum five-year follow-up. Patient-Reported Outcomes Measurement Information System Physical Function Short Form 10a (PROMIS PF-10a) scores were collected preoperatively and at one-year postoperatively. Patients were classified based on experiencing MCID-I, MCID-W, or "no change" after TJA (scores between MCID-I and MCID-W). MCID-W and MCID-I values were determined by a distribution-based method. Revision-free survival was compared at 1 year, 3 years, and 5 years postoperatively. RESULTS: The overall revision rate for the entire TJA cohort was 1.1% at 1 year, 1.8% at 3 years, and 2.2% at 5 years postoperatively. TJA patients who experienced MCID-W had a higher revision rate than MCID-I patients at 1 year (3.6 versus 0.8%, P < 0.001), 3 years (5.3 versus 1.1%, P < 0.001), and 5 years postoperatively (5.7 versus 1.5%, P < 0.001). Similarly, stratifying into TKAs and THAs revealed an association between MCID-W and higher revision rates. Revision-free survival curves for MCID-W patients revealed lower survival at 1 year (P < 0.001), 3 years (P < 0.001), and 5 years (P < 0.001). CONCLUSIONS: Patients experiencing the MCID-W are more likely to undergo revision surgery at 1, 3, and 5 years following both THA and TKA procedures. The MCID-W may be a useful tool to help identify postoperative THA and TKA patients at highest risk for revision surgery. Future studies utilizing MCID-W as a predictive tool are needed to determine its effectiveness in optimizing TJA patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts General Hospital, Boston, USA.
- Newton Wellesley Hospital, Newton, USA.
- Massachusetts General Hospital, Boston, USA. nxs641@case.edu.
- Newton Wellesley Hospital, Newton, USA. nxs641@case.edu.
Zitieren
APA
Lim, P. L., Sauder, N., Peterson, S. L., Melnic, C. M., & Bedair, H. S. (2025). Total joint arthroplasty patients who experience the minimal clinically important difference for worsening (MCID-W) have higher revision rates at 1, 3, and 5 years postoperatively:. Archives of Orthopaedic and Trauma Surgery. https://doi.org/10.1007/s00402-025-06068-4
Vancouver
Lim PL, Sauder N, Peterson SL, Melnic CM, Bedair HS. Total joint arthroplasty patients who experience the minimal clinically important difference for worsening (MCID-W) have higher revision rates at 1, 3, and 5 years postoperatively:. Archives of Orthopaedic and Trauma Surgery. 2025. doi:10.1007/s00402-025-06068-4
BibTeX
@article{Lim2025,
author = {Lim, Perry L and Sauder, Nicholas and Peterson, Shian L and Melnic, Christopher M and Bedair, Hany S},
title = {Total joint arthroplasty patients who experience the minimal clinically important difference for worsening (MCID-W) have higher revision rates at 1, 3, and 5 years postoperatively:},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2025},
doi = {10.1007/s00402-025-06068-4}
}
EUVIMED